1. Home
  2. ORIC vs RMR Comparison

ORIC vs RMR Comparison

Compare ORIC & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • RMR
  • Stock Information
  • Founded
  • ORIC 2014
  • RMR 1986
  • Country
  • ORIC United States
  • RMR United States
  • Employees
  • ORIC N/A
  • RMR N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • RMR Professional Services
  • Sector
  • ORIC Health Care
  • RMR Consumer Discretionary
  • Exchange
  • ORIC Nasdaq
  • RMR Nasdaq
  • Market Cap
  • ORIC 362.9M
  • RMR 290.8M
  • IPO Year
  • ORIC 2020
  • RMR N/A
  • Fundamental
  • Price
  • ORIC $11.10
  • RMR $17.72
  • Analyst Decision
  • ORIC Strong Buy
  • RMR
  • Analyst Count
  • ORIC 9
  • RMR 0
  • Target Price
  • ORIC $18.29
  • RMR N/A
  • AVG Volume (30 Days)
  • ORIC 949.2K
  • RMR 119.6K
  • Earning Date
  • ORIC 08-11-2025
  • RMR 08-05-2025
  • Dividend Yield
  • ORIC N/A
  • RMR 10.17%
  • EPS Growth
  • ORIC N/A
  • RMR N/A
  • EPS
  • ORIC N/A
  • RMR 1.06
  • Revenue
  • ORIC N/A
  • RMR $197,672,000.00
  • Revenue This Year
  • ORIC N/A
  • RMR $323.25
  • Revenue Next Year
  • ORIC N/A
  • RMR $1.07
  • P/E Ratio
  • ORIC N/A
  • RMR $16.65
  • Revenue Growth
  • ORIC N/A
  • RMR N/A
  • 52 Week Low
  • ORIC $3.90
  • RMR $13.48
  • 52 Week High
  • ORIC $14.67
  • RMR $26.43
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 66.82
  • RMR 68.35
  • Support Level
  • ORIC $10.42
  • RMR $16.94
  • Resistance Level
  • ORIC $11.50
  • RMR $17.80
  • Average True Range (ATR)
  • ORIC 0.62
  • RMR 0.42
  • MACD
  • ORIC -0.03
  • RMR 0.06
  • Stochastic Oscillator
  • ORIC 83.30
  • RMR 94.90

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About RMR The RMR Group Inc.

The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.

Share on Social Networks: